Susquehanna International Group, LLP Grifols Sa Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$6.27 - $7.7 $479,027 - $588,280	76,400 Added 17.02%	525,200 $3.31 Million
Q1 2024 May 07, 2024	BUY	$5.47 - $11.38 $2.33 Million - $4.85 Million	426,500 Added 1912.56%	448,800 $3 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $615,258 - $922,488	-79,800 Reduced 78.16%	22,300 $257,000
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $388,476 - $475,676	43,600 Added 74.53%	102,100 $933,000
Q2 2023 Aug 11, 2023	BUY	$7.14 - $9.29 $147,798 - $192,302	20,700 Added 54.76%	58,500 $535,000
Q1 2023 May 16, 2023	BUY	$6.65 - $10.69 $150,955 - $242,663	22,700 Added 150.33%	37,800 $278,000
Q4 2022 Feb 14, 2023	SELL	$5.96 - $8.53 $79,268 - $113,448	-13,300 Reduced 46.83%	15,100 $128,000
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $45,220 - $108,680	7,600 Added 36.54%	28,400 $175,000

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.99B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.